ArticleJournal for immunotherapy of cancer2018

Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma.

Evidio Domingo-Musibay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.